Molecular Medicine is an open access journal publishing recent findings that elucidate disease pathogenesis at the molecular or physiological level, which may lead to the design of specific tools for disease diagnosis, treatment, or prevention. Manuscripts containing material relevant to the genetic, molecular, or cellular basis of key physiologic or disease processes are considered for publication. Manuscripts submitted to Molecular Medicine should describe the implications of the results for human disease and medicine, at a level approachable by our broad audience.

Criteria to consider for studies involving lnc-RNAs or micro-RNAs:

·        As lncRNAs and miRNAs have multiple targets, claims of their function mediated by a single target or pathway will not be accepted, unless multiple additional targets are investigated to support functional specificity.

·        The rationale to investigate a specific lncRNA or miRNA needs to be specified upfront in the introduction and justified in the context of other miRNAs known to be functional in that specific field.

·        The proposed function of the lnc-RNA or miRNA should be validated by gain and loss of function studies.

·        Primary cells should be used whenever possible to confirm findings in cell lines.

·        In depth investigation in the signaling pathway(s) regulated by the RNA species should be conducted.

·        Insight into the regulation of the RNA species and how it relates to the pathologic state should be provided.

·        If applicable: Details of initial screen used to identify RNA species involvement in pathway/disease (number of subjects, statistical tests employed, percent change from controls).

Editor-in-Chief
Betty Diamond, The Feinstein Institutes for Medical Research, USA
Executive Editor
Valentin A Pavlov, The Feinstein Institutes for Medical Research, USA
Managing Editor
Maria Ruggieri, The Feinstein Institutes for Medical Research, USA
Coordinating Editor
Sonya Vanpatten, The Feinstein Institutes for Medical Research, USA
Contributing Editors
Frederick W Alt, Howard Hughes Medical Institute, USA
Marco E Bianchi, San Raffaele Scientific Institute, Italy
Timothy Billiar, University of Pittsburgh, USA
Uli Broedl, Boehringer Ingelheim, Canada
Michael Bukrinsky, George Washington University, USA 
Patrice D Cani, UCLouvain, University of Louvain, Belgium
Anthony Cerami, Araim Pharmaceuticals, USA
Nicholas Chiorazzi, The Feinstein Institutes for Medical Research, USA 
José C Crispín Acuña, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico
Robert J Desnick, Mount Sinai School of Medicine, USA 
Charles A Dinarello, University of Colorado Health Sciences, USA 
Hannelore Ehrenreich, Max-Planck Institute for Experimental Medicine, Germany
Laurie Glimcher, Weill Cornell Medicine, USA
Paul Greengard, Rockefeller University, USA 
Peter K Gregersen, The Feinstein Institutes for Medical Research, USA 
Alexis M Kalergis, Pontificia Universidad Católica de Chile, Chile
Lars Klareskog, Karolinska Institute, Sweden
Mike McCune, University of California at San Francisco, USA
Carl F Nathan, Weill Cornell Medicine, USA
Haitao Niu, Peking Union Medical College, China
Bert W O'Malley, Baylor College of Medicine, USA
Athanasios G Papavassiliou, University of Athens, Greece
Marc H Symons, The Feinstein Institutes for Medical Research, USA
Csaba Szabo, University of Fribourg, Switzerland
Christoph Thiemermann, Queen Mary University London, UK
Kevin J Tracey, The Feinstein Institute for Medical Research, USA
H Shaw Warren, Massachusetts General Hospital, USA
Associate Editors
Dimitar B Avtanski, The Feinstein Institutes for Medical Research, USA
Lior Brimberg, The Feinstein Institutes for Medical Research, USA
Max Brenner, The Feinstein Institutes for Medical Research, USA
Eric H Chang, The Feinstein Institutes for Medical Research, USA
Salvatore Coniglio, Kean University, USA
Harshil Dhruv, The Translational Genomics Research Institute, USA
Maya Frankfurt, Hofstra North Shore-LIJ School of Medicine, USA
Paolo Guarnieri, Boehringer Ingelheim, USA
Jared Huston, The Feinstein Institutes for Medical Research, USA
Sun Jung Kim, The Feinstein Institutes for Medical Research, USA
Ben Lu, Central South University, China
Susan Malkiel, The Feinstein Institutes for Medical Research, USA
Philippe Marambaud, The Feinstein Institutes for Medical Research, USA
Kaie Ojamaa, New York Institute of Technology, USA
Susanna Park, University of California Davis, USA
Shresh Pathak, The Feinstein Institutes for Medical Research, USA
Ameya P Patil, Medical College of Wisconsin, USA
Doru Paul, Weill Cornell Medicine, USA
Elisabeth Ploran, Hofstra North Shore-LIJ School of Medicine, USA
Viswanathan Rajagopalan, New York Institute of Technology, USA
Bodour Salhia, University of Southern California, USA
Frances Santiago-Schwarz, The Feinstein Institutes for Medical Research, USA
Olga Savinova, New York Institute of Technology, USA
Amnon Schlegel, University of Utah, USA
Kim R Simpfendorfer, The Feinstein Institutes for Medical Research, USA
Myoungsun Son, The Feinstein Institutes for Medical Research, USA
Joel Stern, Hofstra North Shore-LIJ School of Medicine, USA
Xingmin Sun, University of South Florida, USA
Nhan Tran, Mayo Clinic, USA
Weng-Lang Yang, The Feinstein Institutes for Medical Research, USA
Sophia Yancopoulos, The Feinstein Institutes for Medical Research, USA
Xinhua Zhu, The Feinstein Institutes for Medical Research, USA